AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Abbott to distribute 2 cancer detection tests.(Chicago Tribune)
Shares of biotechnology firm Vysis Inc. soared more than 20 percent Thursday on news that Abbott Laboratories will distribute two of its cancer detection tests.
The deal is a boon for Vysis, a small Downers Grove, Ill.-based biotech company, providing a strong endorsement of its products, officials said. Abbott has exclusive rights to distribute Vysis' DNA-based tests for bladder and breast cancers to thousands of doctors and hospitals in North American and Europe.
The agreement also gives Abbott an exclusive option to distribute the tests _ Vysis' PathVysion HER-2 assay for breast cancer and UroVysion test for bladder cancer _ in South America and the Asian …
-
- Abbott attributes falling profits of TAP Pharmaceutical to legal...
-
News wire article from: Knight Ridder/Tribune News Service
Japsen, Bruce
January 16, 2001
700+ words
-
- Abbott Labs to beef up R&D with new acquisition.(Chicago Tribune)
-
News wire article from: Knight Ridder/Tribune News Service
Japsen, Bruce
December 15, 2000
700+ words
-
- New AIDS drug from Abbott works longer than Viracept.(Chicago Tribune)
-
News wire article from: Knight Ridder/Tribune News Service
Japsen, Bruce
September 18, 2000
700+ words
-
- Abbott to team with Medtronics on coated stents.(Chicago Tribune)
-
News wire article from: Knight Ridder/Tribune News Service
Japsen, Bruce
May 9, 2002
700+ words
-
- Abbott Labs reaches settlement in fraud case; waiting for federal court...
-
News wire article from: Knight Ridder/Tribune News Service
Japsen, Bruce
June 26, 2003
700+ words
